Dersleri yüzünden oldukça stresli bir ruh haline sikiş hikayeleri bürünüp özel matematik dersinden önce rahatlayabilmek için amatör pornolar kendisini yatak odasına kapatan genç adam telefonundan porno resimleri açtığı porno filmini keyifle seyir ederek yatağını mobil porno okşar ruh dinlendirici olduğunu iddia ettikleri özel sex resim bir masaj salonunda çalışan genç masör hem sağlık hem de huzur sikiş için gelip masaj yaptıracak olan kadını gördüğünde porn nutku tutulur tüm gün boyu seksi lezbiyenleri sikiş dikizleyerek onları en savunmasız anlarında fotoğraflayan azılı erkek lavaboya geçerek fotoğraflara bakıp koca yarağını keyifle okşamaya başlar
Reach Us
+1-947-333-4405
GET THE APP
Investigations Of Anticoagulation Therapy In Patients With COVID-19 | 109880
ISSN: 2332-0877
Journal of Infectious Diseases & Therapy
Open Access
Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
COVID-19 threat virus. From 2020 to the present day, a ludicrous
number of lives have been claimed. New coronary artery disease
is a phonological disorder of the neurological, cardiological,
immune, and immune systems. The new coronavirus is a major
cause of thromboembolic disorders, primarily immobilization. In the
report and the new literature, it was shown that NOAC reduced
the mortality of the patients. Discussion about new and the newest
literature gave us the possibility to generate research questions
about the effect of NOAC on blood flow during COVID-19.
Our goal was to study the anticoagulant effect of NOAC on
aggregation of erythrocytes and platelets. We didn��?t write the
name of the medicine which we used in our experiment to avoid
advertising.
Materials and methods
We examined the sample of healthy people (n = 5), and also
sample from Covid-19patients. The mean age of both groups was
60 �?±5,5 years. We dispensed the effective dose of the preparation
on 4 ml of blood in a sample, following the instructions for the
preparation. For the control group, we had taken the same dose.
We used the original texture analyzation system (Leitz, Germany).
For creating data we used the statistical analysis system Origin 8.1.
Result
We found that the aggregation of erythrocytes in blood samples
of healthy people was different from erythrocytes in blood samples
of patients with Covid-19 by 20%. The aggregation of platelets in
blood samples of Covid-19 was different, than the aggregation of
platelets in blood samples of healthy people by 30%.
After the addition of the anticoagulant in the sample, we reduced
the erythrocyte aggregation and the thrombocyte aggregation in
blood samples with Covid-19. We had advertised this study to Ethic
Committee of our University.
The aggregative properties of red blood are leading to blood
flow. RBC aggregation and platelet aggregation are one of the
factors in the formation of a blood clot and stasis in the blood,
which is very characteristic of Covid-19.
Discussion
It is obvious that the anticoagulant has a positive effect on the
thinning of "red blood". The aggregative properties of red
blood are leading for blood flow. RBC aggregation and platelet
aggregation are one of the factors in the formation of a blood clot
and stasis in the blood, which is very characteristic of Covid-19.
Conclusion
It is necessary to continue research in this direction. We should
compare different anticoagulants with each other and in the
future start clinical trials to compare the effectiveness of different
anticoagulants in the direction of blood flow in a group of patients
with Covid-19.
Keywords: NOAC (Direct Oral Anticoagulant); Anticoagulant;
Aggregation of blood cells; Blood flow; COVID-19
Biography
Rishu Bansal pursuing her MD programme from European University, Georgia. Her research interest mainly focusses on Vaccines, Immunology & Pathology.
Relevant Topics
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals